Cargando…

Dysregulated Inflammation During Obesity: Driving Disease Severity in Influenza Virus and SARS-CoV-2 Infections

Acute inflammation is a critical host defense response during viral infection. When dysregulated, inflammation drives immunopathology and tissue damage. Excessive, damaging inflammation is a hallmark of both pandemic influenza A virus (IAV) infections and Severe Acute Respiratory Syndrome-Coronaviru...

Descripción completa

Detalles Bibliográficos
Autores principales:	Hulme, Katina D., Noye, Ellesandra C., Short, Kirsty R., Labzin, Larisa I.
Formato:	Online Artículo Texto
Lenguaje:	English
Publicado:	Frontiers Media S.A. 2021
Materias:	Immunology
Acceso en línea:	https://www.ncbi.nlm.nih.gov/pmc/articles/PMC8581451/ https://www.ncbi.nlm.nih.gov/pubmed/34777390 http://dx.doi.org/10.3389/fimmu.2021.770066

Ejemplares similares

Influenza Virus and Glycemic Variability in Diabetes: A Killer Combination?
por: Hulme, Katina D., et al.
Publicado: (2017)

Type I Diabetes Mellitus Increases the Cardiovascular Complications of Influenza Virus Infection
por: Sinclair, Jane E., et al.
Publicado: (2021)

Respiratory Tract Infections in Diabetes – Lessons From Tuberculosis and Influenza to Guide Understanding of COVID-19 Severity
por: Al-Sayyar, Amnah, et al.
Publicado: (2022)

High glucose levels increase influenza-associated damage to the pulmonary epithelial-endothelial barrier
por: Hulme, Katina D, et al.
Publicado: (2020)

SARS-CoV-2 infection dysregulates NAD metabolism
por: Izadpanah, Amin, et al.
Publicado: (2023)

Glycemic Variability in Diabetes Increases the Severity of Influenza
por: Marshall, Rebecca J., et al.
Publicado: (2020)

Early Host Interactions That Drive the Dysregulated Response in Sepsis
por: Kerrigan, Steven W., et al.
Publicado: (2019)

A paucigranulocytic asthma host environment promotes the emergence of virulent influenza viral variants
por: Hulme, Katina D, et al.
Publicado: (2021)

Immunometabolic Dysregulation at the Intersection of Obesity and COVID-19
por: Khwatenge, Collins N., et al.
Publicado: (2021)

Obesity-Driven Deficiencies of Specialized Pro-resolving Mediators May Drive Adverse Outcomes During SARS-CoV-2 Infection
por: Pal, Anandita, et al.
Publicado: (2020)

The extracellular microenvironment in immune dysregulation and inflammation in retinal disorders
por: Biasella, Fabiola, et al.
Publicado: (2023)

Comparative Review of SARS-CoV-2, SARS-CoV, MERS-CoV, and Influenza A Respiratory Viruses
por: Abdelrahman, Zeinab, et al.
Publicado: (2020)

Immune-profiling of SARS-CoV-2 viremic patients reveals dysregulated innate immune responses
por: Sun, Xiaoming, et al.
Publicado: (2022)

SARS-CoV-2 mediated dysregulation in cell signaling events drives the severity of COVID-19
por: Aktar, Salma, et al.
Publicado: (2022)

No Role for Mast Cells in Obesity-Related Metabolic Dysregulation
por: Chmelař, Jindřich, et al.
Publicado: (2016)

Endothelial cells are not productively infected by SARS‐CoV‐2
por: Schimmel, Lilian, et al.
Publicado: (2021)

Platelet-Mediated NET Release Amplifies Coagulopathy and Drives Lung Pathology During Severe Influenza Infection
por: Kim, Seok-Joo, et al.
Publicado: (2021)

Severe COVID-19: NLRP3 Inflammasome Dysregulated
por: van den Berg, Daan F., et al.
Publicado: (2020)

Changes in Circadian Rhythms Dysregulate Inflammation in Ageing: Focus on Leukocyte Trafficking
por: Nathan, Poppy, et al.
Publicado: (2021)

Persistent Inflammation and Nitric Oxide Dysregulation Are Transcriptomic Blueprints of Subglottic Stenosis
por: Nguyen, Hoang C. B., et al.
Publicado: (2021)

HLA-C dysregulation as a possible mechanism of immune evasion in SARS-CoV-2 and other RNA-virus infections
por: Loi, Eleonora, et al.
Publicado: (2022)

Editorial: Dysregulation of immunity predisposing to severe COVID-19 infection
por: Halwani, Rabih, et al.
Publicado: (2022)

Inflammation-mediated fibroblast activation and immune dysregulation in collagen VII-deficient skin
por: Anderson-Crannage, Morgan, et al.
Publicado: (2023)

Comparison of C-reactive protein with distinct hyperinflammatory biomarkers in association with COVID-19 severity, mortality and SARS-CoV-2 variants
por: Paranga, Tudorita Gabriela, et al.
Publicado: (2023)

SARS-CoV-2 Antibodies Mediate Complement and Cellular Driven Inflammation
por: Jarlhelt, Ida, et al.
Publicado: (2021)

Thrombosis in Psoriasis: Cutaneous Cytokine Production as a Potential Driving Force of Haemostatic Dysregulation and Subsequent Cardiovascular Risk
por: Visser, Maria J. E., et al.
Publicado: (2021)

Dysregulation of Intestinal Epithelial Cell RIPK Pathways Promotes Chronic Inflammation in the IBD Gut
por: Garcia-Carbonell, Ricard, et al.
Publicado: (2019)

Transcriptomic Signature Differences Between SARS-CoV-2 and Influenza Virus Infected Patients
por: Bibert, Stéphanie, et al.
Publicado: (2021)

Antigenic Determinants of SARS-CoV-2-Specific CD4(+) T Cell Lines Reveals M Protein-Driven Dysregulation of Interferon Signaling
por: Gazzinelli-Guimaraes, Pedro H., et al.
Publicado: (2022)

Inflammation Drives Coagulopathies in Sars-Cov-2 Patients
por: Sim, Martha MS, et al.
Publicado: (2020)

Cytokines and Lipid Mediators of Inflammation in Lungs of SARS-CoV-2 Infected Mice
por: Dubuc, Isabelle, et al.
Publicado: (2022)

Dysregulated inflammasome activity in intestinal inflammation – Insights from patients with very early onset IBD
por: Illig, David, et al.
Publicado: (2022)

The dysregulation of immune cells induced by uric acid: mechanisms of inflammation associated with hyperuricemia and its complications
por: Li, Delun, et al.
Publicado: (2023)

Role of CD39 in COVID-19 Severity: Dysregulation of Purinergic Signaling and Thromboinflammation
por: Díaz-García, Elena, et al.
Publicado: (2022)

Acute and chronic lung inflammation drives changes in epithelial glycans
por: Alvarez, Carlos A., et al.
Publicado: (2023)

SARS-CoV-2 Induces Lymphocytopenia by Promoting Inflammation and Decimates Secondary Lymphoid Organs
por: Xiang, Qun, et al.
Publicado: (2021)

IL-6 Mediated Transcriptional Programming of Naïve CD4+ T Cells in Early Rheumatoid Arthritis Drives Dysregulated Effector Function
por: Ridgley, Laura A., et al.
Publicado: (2019)

SARS-CoV-2 specific immune responses in overweight and obese COVID-19 patients
por: Onyango, Therese Bredholt, et al.
Publicado: (2023)

Metabolic Profiling at COVID-19 Onset Shows Disease Severity and Sex-Specific Dysregulation
por: Ceballos, Francisco C., et al.
Publicado: (2022)

Comparable bidirectional neutrophil immune dysregulation between Kawasaki disease and severe COVID-19
por: Chen, Kuang-Den, et al.
Publicado: (2022)

Cannot write session to /tmp/vufind_sessions/sess_569dkitqe79qpd6ke48hmk6j81